SEC Form 4 · accession 0001645627-17-000056
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
May 5, 2017
Accepted (ET)
May 9, 2017 · 1:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 5, 2017 | P | 1,000 | $0.077 | A | 20,652,949 | D | |
| Common Stock | May 5, 2017 | P | 1,000 | $0.077 | A | 20,653,949 | D | |
| Common Stock | May 5, 2017 | P | 1,000 | $0.075 | A | 20,654,949 | D | |
| Common Stock | May 5, 2017 | P | 1,000 | $0.0748 | A | 20,655,949 | D | |
| Common Stock | May 5, 2017 | P | 1,000 | $0.075 | A | 20,656,949 | D | |
| Common Stock | May 5, 2017 | P | 1,000 | $0.075 | A | 20,657,949 | D | |
| Common Stock | May 5, 2017 | P | 1,000 | $0.0768 | A | 20,658,949 | D | |
| Common Stock | May 5, 2017 | P | 1,000 | $0.0768 | A | 20,659,949 | D | |
| Common Stock | May 5, 2017 | P | 1,000 | $0.077 | A | 20,660,949 | D | |
| Common Stock | May 5, 2017 | P | 1,000 | $0.077 | A | 20,661,949 | D |
Table II — derivative securities
No Table II lines on this filing.